231 related articles for article (PubMed ID: 19219435)
1. [Genome-wide expression profiling as a clinical tool: are we there yet?].
Geyer FC; Decker T; Reis-Filho JS
Pathologe; 2009 Mar; 30(2):141-6. PubMed ID: 19219435
[TBL] [Abstract][Full Text] [Related]
2. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
3. The role of molecular analysis in breast cancer.
Geyer FC; Marchio C; Reis-Filho JS
Pathology; 2009 Jan; 41(1):77-88. PubMed ID: 19089743
[TBL] [Abstract][Full Text] [Related]
4. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in breast cancer: classification, prognostication, and prediction.
Reis-Filho JS; Pusztai L
Lancet; 2011 Nov; 378(9805):1812-23. PubMed ID: 22098854
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer prognostic classification in the molecular era: the role of histological grade.
Rakha EA; Reis-Filho JS; Baehner F; Dabbs DJ; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Richardson AL; Schnitt SJ; Schmitt FC; Tan PH; Tse GM; Badve S; Ellis IO
Breast Cancer Res; 2010; 12(4):207. PubMed ID: 20804570
[TBL] [Abstract][Full Text] [Related]
8. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
Weigelt B; Baehner FL; Reis-Filho JS
J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
[TBL] [Abstract][Full Text] [Related]
9. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue.
Hartmann K; Schlombs K; Laible M; Gürtler C; Schmidt M; Sahin U; Lehr HA
Diagn Pathol; 2018 Oct; 13(1):83. PubMed ID: 30342538
[TBL] [Abstract][Full Text] [Related]
10. Integrating breast cancer genetics into clinical practice.
Mukherjee A; Rakha EA
Womens Health (Lond); 2012 Jan; 8(1):99-112. PubMed ID: 22171779
[TBL] [Abstract][Full Text] [Related]
11. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
12. Histological types of breast cancer: how special are they?
Weigelt B; Geyer FC; Reis-Filho JS
Mol Oncol; 2010 Jun; 4(3):192-208. PubMed ID: 20452298
[TBL] [Abstract][Full Text] [Related]
13. Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Iwamoto T; Kelly C; Mizoo T; Nogami T; Motoki T; Shien T; Taira N; Hayashi N; Niikura N; Fujiwara T; Doihara H; Matsuoka J
Clin Breast Cancer; 2016 Apr; 16(2):95-100.e1. PubMed ID: 26631838
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling: changing face of breast cancer classification and management.
Wesolowski R; Ramaswamy B
Gene Expr; 2011; 15(3):105-15. PubMed ID: 22268293
[TBL] [Abstract][Full Text] [Related]
15. [Gene expression based multigene prognostic and predictive tests in breast cancer].
Pénzváltó Z; Mihály Z; Gyorffy B
Magy Onkol; 2009 Dec; 53(4):351-9. PubMed ID: 20071307
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
[TBL] [Abstract][Full Text] [Related]
17. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
18. Advances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized Medicine.
Rosa M
Cancer Control; 2015 Apr; 22(2):211-9. PubMed ID: 26068767
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer expression profiling: the impact of microarray testing on clinical decision making.
Modlich O; Prisack HB; Bojar H
Expert Opin Pharmacother; 2006 Oct; 7(15):2069-78. PubMed ID: 17020433
[TBL] [Abstract][Full Text] [Related]
20. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
Abd El-Rehim DM; Ball G; Pinder SE; Rakha E; Paish C; Robertson JF; Macmillan D; Blamey RW; Ellis IO
Int J Cancer; 2005 Sep; 116(3):340-50. PubMed ID: 15818618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
